Literature DB >> 21682749

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Mark Boguniewicz1, Donald Y M Leung.   

Abstract

Atopic dermatitis (AD) is an important chronic or relapsing inflammatory skin disease that often precedes asthma and allergic disorders. New insights into the genetics and pathophysiology of AD point to an important role of structural abnormalities in the epidermis as well as immune dysregulation not only for this skin disease but also for the development of asthma and allergies. Patients with AD have a unique predisposition to colonization or infection by microbial organisms, most notably Staphylococcus aureus and herpes simplex virus. Measures directed at healing and protecting the skin barrier and addressing the immune dysregulation are essential in the treatment of patients with AD, and early intervention may improve outcomes for both the skin disease as well as other target organs.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682749      PMCID: PMC3122139          DOI: 10.1111/j.1600-065X.2011.01027.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  133 in total

1.  Severe refractory atopic dermatitis in adults is highly atopic.

Authors:  Bryn H Salt; Mark Boguniewicz; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2006-12-27       Impact factor: 10.793

Review 2.  The socioeconomic impact of atopic dermatitis in the United States: a systematic review.

Authors:  Anthony J Mancini; Kellee Kaulback; Sarah L Chamlin
Journal:  Pediatr Dermatol       Date:  2008 Jan-Feb       Impact factor: 1.588

3.  Our evolving understanding of the functional role of filaggrin in atopic dermatitis.

Authors:  Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

4.  Vaccine assembly from surface proteins of Staphylococcus aureus.

Authors:  Yukiko K Stranger-Jones; Taeok Bae; Olaf Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

5.  Household peanut consumption as a risk factor for the development of peanut allergy.

Authors:  Adam T Fox; Peter Sasieni; George du Toit; Huma Syed; Gideon Lack
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

6.  Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum.

Authors:  Michael D Howell; James F Jones; Kevin O Kisich; Joanne E Streib; Richard L Gallo; Donald Y M Leung
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

7.  Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13.

Authors:  Rui He; Hye Young Kim; Juhan Yoon; Michiko K Oyoshi; Andrew MacGinnitie; Sho Goya; Eva-Jasmin Freyschmidt; Paul Bryce; Andrew N J McKenzie; Dale T Umetsu; Hans C Oettgen; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2009-10       Impact factor: 10.793

8.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

9.  Cytokine modulation of atopic dermatitis filaggrin skin expression.

Authors:  Michael D Howell; Byung Eui Kim; Peisong Gao; Audrey V Grant; Mark Boguniewicz; Anna Debenedetto; Lynda Schneider; Lisa A Beck; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2007-05-23       Impact factor: 10.793

10.  Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations.

Authors:  Gráinne M O'Regan; Linda E Campbell; Heather J Cordell; Alan D Irvine; W H Irwin McLean; Sara J Brown
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

View more
  257 in total

Review 1.  Controversies in Allergy: Food Testing and Dietary Avoidance in Atopic Dermatitis.

Authors:  Rachel G Robison; Anne Marie Singh
Journal:  J Allergy Clin Immunol Pract       Date:  2018-11-27

2.  Adaptive Immunity Against Staphylococcus aureus.

Authors:  Hatice Karauzum; Sandip K Datta
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

3.  Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.

Authors:  Lei Bao; Jaime B Alexander; Huayi Zhang; Kui Shen; Lawrence S Chan
Journal:  J Interferon Cytokine Res       Date:  2016-02-26       Impact factor: 2.607

Review 4.  Food-Related Contact Dermatitis, Contact Urticaria, and Atopy Patch Test with Food.

Authors:  Alexandra Walter; Marlene Seegräber; Andreas Wollenberg
Journal:  Clin Rev Allergy Immunol       Date:  2019-02       Impact factor: 8.667

5.  Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis.

Authors:  Victoria Dimitriades; Paulo C Rodriguez; Jovanny Zabaleta; Augusto C Ochoa
Journal:  Ann Allergy Asthma Immunol       Date:  2014-07-11       Impact factor: 6.347

Review 6.  Trp channels and itch.

Authors:  Shuohao Sun; Xinzhong Dong
Journal:  Semin Immunopathol       Date:  2015-09-18       Impact factor: 9.623

7.  NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.

Authors:  Delong Jiao; Chun-Kwok Wong; Huai-Na Qiu; Jie Dong; Zhe Cai; Man Chu; Kam-Lun Hon; Miranda Sin-Man Tsang; Christopher Wai-Kei Lam
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

8.  Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Authors:  Cezmi A Akdis; Claus Bachert; Cemal Cingi; Mark S Dykewicz; Peter W Hellings; Robert M Naclerio; Robert P Schleimer; Dennis Ledford
Journal:  J Allergy Clin Immunol       Date:  2013-04-12       Impact factor: 10.793

9.  Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses.

Authors:  Shin Yong Park; Xuefang Jing; Dipika Gupta; Roman Dziarski
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

Review 10.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.